MYOCD and myocardial infarction: In a myocardial infarction (MI) model, administration of Sall4 has demonstrated reparative effects, including its ability to promote the transdifferentiation of myofibroblast into cardiomyocyte-like cells, in conjunction with GMT, Myocd, and two chemical compounds [161].